Chongqing Zhifei Biological Products Dividends and Buybacks
Dividend criteria checks 5/6
Chongqing Zhifei Biological Products is a dividend paying company with a current yield of 2.65% that is well covered by earnings.
Key information
2.7%
Dividend yield
0.4%
Buyback Yield
| Total Shareholder Yield | 3.1% |
| Future Dividend Yield | 2.3% |
| Dividend Growth | 21.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.800 |
| Payout ratio | 52% |
Recent dividend and buyback updates
Recent updates
Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Share Price Boosted 45% But Its Business Prospects Need A Lift Too
Sep 30
Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122) Analysts Are More Bearish Than They Used To Be
Sep 03Calculating The Fair Value Of Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122)
Aug 23We Think Chongqing Zhifei Biological Products (SZSE:300122) Can Stay On Top Of Its Debt
Jul 26Why Investors Shouldn't Be Surprised By Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Low P/E
May 21Earnings Miss: Chongqing Zhifei Biological Products Co., Ltd. Missed EPS By 35% And Analysts Are Revising Their Forecasts
Apr 26Is Chongqing Zhifei Biological Products (SZSE:300122) A Risky Investment?
Mar 26Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300122's dividend payments have been volatile in the past 10 years.
Growing Dividend: 300122's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Chongqing Zhifei Biological Products Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300122) | 2.7% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Biotechs) | 1.2% |
| Analyst forecast (300122) (up to 3 years) | 2.3% |
Notable Dividend: 300122's dividend (2.65%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 300122's dividend (2.65%) is in the top 25% of dividend payers in the CN market (2.12%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (52%), 300122's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: At its current cash payout ratio (82.2%), 300122's dividend payments are covered by cash flows.